BioAlliance Pharma Announces the Forthcoming Extension of Phase II Validive® Trials

News   Feb 15, 2013

 
BioAlliance Pharma Announces the Forthcoming Extension of Phase II Validive® Trials
 
 
 

RELATED ARTICLES

Drug Discovery Alliance Formed to Help Increase Drug Development Success Rate

News

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

READ MORE

First Ever Online Event Focused on Cannabis Science

News

Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.

READ MORE

MicroRNA Helps Cancer Evade Immune System

News

Salk researchers discover how oxygen-deprived tumors survive body’s immune response.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE